Occam Recruits Sapna Srivastava to the Board of Nuvalent

Nuvalent, an F-Prime/Deerfield investment, develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events and drive more durable responses. The company went public in 2021 generating $166M.
‍

In late 2021, Occam recruited Sapna Srivastava, PhD to the Board of Nuvalent. Sapna began her career as an equity analyst on Wall Street before taking on operating CFO roles at innovative biotechs like eGenesis, VelosBio, and Intellia.

Sapna Srivastava
7.5.21
Board

View recent Placements

Placement Card Link
Paul Sekhri
11.16.26
Paul Sekhri Recruited as Exec Chair to Laverock Therapeutics by Occam Global
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
Placement Card Link
Parker Moss
11.16.26
Occam Places CEO for UK-Based Laverock Therapeutics
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
Placement Card Link
Rima Alameddine
10.23.26
Former NVIDIA Leader Joins the Board of Chemify
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.
Placement Card Link
Feroze Ujjainwalla
10.9.26
Occam Places CCO at Constructive Bio
This is some text inside of a div block.
This is some text inside of a div block.
This is some text inside of a div block.

DISCOVER OCCAM GLOBAL

Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide.  Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.

Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression.  Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.